文献速递临床试验与 GCP流行病学与生物统计

LifeSpan自杀预防整群随机对照试验阶梯楔形设计方案

Protocol for a stepped-wedge, cluster randomized controlled trial of the LifeSpan suicide prevention trial in four communities in New South Wales, Australia.
PubMed 文献 · Trials · 2020-04-15

该方案描述在澳大利亚新南威尔士州四个地理区域开展阶梯楔形整群随机对照试验,评估包含九项循证策略的LifeSpan多组分自杀预防模型。主要结局为区域自杀未遂率,自杀死亡率作为次要结局,实施期2年并延伸评估至少24个月。

要点

  • LifeSpan模型整合九项循证策略,覆盖普遍性、选择性和指示性干预。
  • 采用阶梯楔形整群随机设计,四个区域依次进入2年积极实施期。
  • 主要结局为自杀未遂率,自杀死亡率为次要结局。

核心结论

  • 该研究将评估LifeSpan多组分自杀预防模型在四个区域降低自杀未遂和自杀死亡的效果。

研究设计与样本

  • 阶梯楔形整群随机对照试验,在澳大利亚新南威尔士州四个地理定义区域开展。
  • 经过6个月过渡期后,试验点以4个月间隔进入2年积极实施期,评估在完整积极期建立后至少延伸24个月。
  • 分析将评估四个站点因干预产生的变化,主要结局为区域自杀未遂率。

关键数值与推荐

  • LifeSpan模型包含九项循证策略,包括指示性、选择性和普遍性干预,在2年实施期内同时提供给社区和医疗系统。
  • 主要结局为所涉区域的自杀未遂率,每个站点内自杀死亡率为次要结局。

临床怎么用

  • 若被证明有效,LifeSpan模型可在澳大利亚社区更广泛地推广,以应对上升的自杀率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite increasing investment in suicide prevention, Australian suicide rates have increased steadily in the past decade. In response to growing evidence for multicomponent intervention models for reducing suicide, the LifeSpan model has been developed as the first multicomponent, evidence-based, system-wide approach to suicide prevention in Australia. The LifeSpan model consists of nine evidence-based strategies. These include indicated, selective and universal interventions which are delivered simultaneously to community and healthcare systems over a 2-year implementation period. This study will evaluate the effectiveness of the LifeSpan model in reducing suicide attempts and suicide deaths in four geographically defined regions in New South Wales, Australia. METHODS: We outline the protocol for a stepped-wedge, cluster randomized controlled trial. Following a 6-month transition phase, the trial sites will move to the 2-year active implementation phase in 4-monthly intervals with evaluation extending a minimum of 24 months after establishment of the full active period. Analysis will be undertaken of the change attributable to the invention across the four sites. The primary outcome for the study is the rate of attempted suicide in the regions involved. Rate of suicide deaths within each site is a secondary outcome. DISCUSSION: If proven effective, the LifeSpan model for suicide prevention could be more widely delivered in Australian communities, providing a valuable new approach to tackle rising suicide rates. LifeSpan has the potential to significantly contribute to the mental health of Australians by improving help-seeking for suicide, facilitating early detection, and improving aftercare to reduce re-attempts. The findings from this research should also contribute to the evidence base for multilevel suicide prevention programs internationally. TRIAL REGISTRATION: Australia New Zealand Clinical Trials Register, ID: ACTRN12617000457347. Prospectively registered on 28 March 2017. https://www.anzctr.org.au/TrialSearch.aspx#&&conditionCode=&dateOfRegistrationFrom=&interventionDescription=&interventionCodeOperator=OR&primarySponsorType=&gender=&distance=&postcode=&pageSize=20&ageGroup=&recruitmentCountryOperator=OR Protocol Version: 1.0, 31 May 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Shand F, Torok M, Cockayne N, et al. Protocol for a stepped-wedge, cluster randomized controlled trial of the LifeSpan suicide prevention trial in four communities in New South Wales, Australia. Trials. 2020. PMID: 32293516. doi:10.1186/s13063-020-04262-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。